Cancer Family
Pleural Mesothelial Neoplasm
CI-CAN-00000322Explore in graph →
Non-malignant34 active trials4 approved drugs6 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000322Explore in graph →
Clinical trials
157 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02269878 | Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma | completed | — | 68 | Ain Shams UniversityOTHER | 1 | Jan 3, 2018 | clinicaltrials |
| NCT01355965 | Autologous Redirected RNA Meso-CIR T Cells | completed | Phase 1 | 18 | University of PennsylvaniaOTHER | 1 | Sep 19, 2017 | clinicaltrials |
| NCT02497508 |
| Nivolumab in Patients With Recurrent Malignant Mesothelioma(NivoMes) |
| completed |
| Phase 2 |
| 33 |
| The Netherlands Cancer InstituteOTHER |
| 0 |
| Sep 14, 2017 |
| clinicaltrials |
| NCT01721018 | Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.(1716-12) | completed | Phase 1 / Phase 2 | 12 | Virttu Biologics LimitedINDUSTRY | 1 | Jun 9, 2017 | clinicaltrials |
| NCT02369198 | MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC | completed | Phase 1 | 27 | Asbestos Diseases Research FoundationOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01211275 | Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma(N08CPA) | completed | Phase 1 / Phase 2 | 32 | The Netherlands Cancer InstituteOTHER | 1 | Feb 28, 2017 | clinicaltrials |
| NCT00571298 | Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma | completed | Phase 1 | 141 | Brigham and Women's HospitalOTHER | 1 | Jan 23, 2017 | clinicaltrials |
| NCT01212367 | Intrapleural Gene Transfer for Pleural Mesothelioma(IFN-alpha) | completed | Phase 1 | 13 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 22, 2015 | clinicaltrials |
| NCT01024946 | Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity | completed | Phase 2 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00867711 | Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients | completed | — | 121 | Istituto Clinico HumanitasOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00165516 | Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate | completed | Phase 2 | 85 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 27, 2014 | clinicaltrials |
| NCT00165555 | Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma | completed | Phase 1 | 70 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 27, 2014 | clinicaltrials |
| NCT01241682 | Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma(PMR-MM-002) | completed | Phase 1 | 10 | Erasmus Medical CenterOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT01243632 | Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment | completed | Phase 2 | 78 | Institute of Oncology LjubljanaOTHER | 1 | Nov 18, 2010 | clinicaltrials |
| NCT00280982 | Dendritic Cell-based Immunotherapy in Mesothelioma | completed | Phase 1 | 10 | Erasmus Medical CenterOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00272558 | Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma | completed | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00386815 | Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 20 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 11, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Jan 3, 2018source: clinicaltrials